Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
2018 has seen extensive health-focused merger and partnership activity, with nearly 840 deals announced as of Q3. Players new to the industry are driving innovation in the traditionally cautious health and life sciences sectors, with unanticipated and innovative alliances poised to revolutionize health care. McDermott Will & Emery is at the forefront of this activity, helping progressive leaders redefine and navigate the health care landscape through Collaborative Transformations – game-changing partnerships that drive bold and creative business solutions.
To view the multimedia release go to:
https://www.multivu.com/players/English/8207752-mcdermott-innovative-partnership-business-collaborations/
Need a healthy life without any health problems? Want to feel better, have more energy and perhaps even live longer? Then look no further than exercise and it is very hard to ignore the benefits of it.
Millions of children in the United States don’t have health coverage. As a result, it may be difficult or impossible for them to get the routine preventive care that keeps them healthy or access to the care they need if they get sick or injured. But, the majority of the nation’s uninsured children are eligible for free or low-cost health coverage through their state Medicaid or Children’s Health Insurance Program (CHIP). They can apply for the comprehensive benefits these programs provide at any time, and now the enrollment process is faster.
To view the multimedia release go to:
https://www.multivu.com/players/English/8102651-hhs-connecting-kids-to-coverage-psa-insurekidsnow/
Health conscious consumers who have struggled to meet their daily required servings of fruits and vegetables—and the vital nutrients that come with—have an easy solution for adding more vitamins to their diet with the introduction of Rader Farms’ Fruit PLUS Vitamins line of enriched berries, arriving in nearly 3,000 new stores across the U.S. this month.
Fruit PLUS Vitamins takes Rader Farms’ premium grade berries that are bursting with rich, sweet flavor and adds nutrients sourced from whole fruits and vegetables to boost vitamin levels by 25 percent, without impacting taste or texture. The end result is a revolutionary new line of frozen fruit that offers supremely delicious taste AND significantly higher nutritional value in a single, easy-to-implement method.*
Rader Farms’ new Fruit PLUS Vitamins has a suggested retail price of $3.49 - $3.99 per 12-ounce package. Frozen fruit lovers can try it now with a $1.00 off coupon and a chance to win a premium Ninja® blender here (http://woobox.com/2288k3). Additionally, a direct link to a downloadable coupon can be found here.
Consider the nutritional value of one cup of traditional unsweetened blueberries when compared to a similar serving of blueberries from Rader Farms’ Fruit PLUS Vitamins line below. It becomes easy to see how smoothie recipes, yogurt toppings and morning cereal rituals might come alive with a boost of nutrition.
To view the multimedia release go to:
http://www.multivu.com/players/English/7630251-rader-farms-fruit-plus-vitamins/
Seqirus announced today that the National Adult and Influenza Immunization Summit (NAIIS) awarded the organization with the 2016 Immunization Excellence Award for best Corporate Campaign. The accolade recognizes Seqirus’ creative and collaborative efforts to improve vaccination awareness and rates during the 2015-16 influenza season. The award was presented yesterday during the NAIIS Summit in Atlanta, Georgia.
“We are pleased to receive this prestigious honor, and thankful to our partners, Families Fighting Flu and several collegiate student organizations, for their dedication to spreading the word about the dangers of flu and encouraging their peers to get vaccinated,” said Dr. Marie Mazur, Vice President of Global Commercial Development and Policy. “Moving forward, Seqirus is committed to building on this season’s success with college students and continuing the important work of flu prevention for all.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7833751-seqirus-national-award-knockoutflu/
The foetus moves its mouth in an exaggerated manner when it hears a human voice. This occurs from the 16th week of pregnancy (with a foetus of 11cm) and only when the voice reaches it through an intravaginal device developed for this purpose. This is one of the conclusions of the study presented by Dr. Álex García-Faura, the Scientific Director of the Institut Marquès, at the 25th European Congress of Perinatal Medicine held in Maastricht (Netherlands).
The study finds that babies hear practically no external noise and only react when sound reaches them through the vagina, which confirms that they hardly hear voices through the mother’s abdomen. Their reactions were studied using Babypod®, a small device that is inserted into the vagina like a tampon and is connected to a mobile phone, enabling the voice of the mother or anyone else to reach the foetus.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7859951-institut-marques-babies-react-mother-voice/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Be a champion for wellness by liking United Concordia’s Facebook page and casting your vote Oct. 1 – Nov. 30 for one of three national charities – American Diabetes Association, March of Dimes or Arthritis Foundation.
Through the “Champions for Wellness” charity program, visitors who “like” United Concordia’s Facebook page can award a total of $25,000 to charity while learning about the connection between oral and overall wellness.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58162-united-concordia-champions-for-wellness-charity-program
Deciding to have a baby is a magical time in any hopeful soon-to-be parent’s life. However, it comes as no surprise that navigating those waters can also be stressful and filled with unknowns. What should be done prior to pregnancy? What changes will new mommy go through physically and emotionally? What steps can parents take prior to the baby’s arrival to make the transition more seamless?
Bayer, the maker of Coppertone®, is revolutionizing the sunscreen experience this season with new Coppertone® Whipped, a transformative sunscreen unlike anything you’ve ever felt before. Not only is Coppertone introducing the first ever whipped sunscreen, it is rolling out a series of engaging activations throughout the summer to launch it, and partnering with everyone from beauty influencers to the Skin Cancer Foundation.
The Whipped line, available in both CLEARLYSheer® and WaterBABIES® Pure & Simple formulas, transforms the sunscreen application process from an ordinary task to an experience people can look forward to before they head out into the sunshine. While many other sunscreen lotions can feel heavy or sticky, Whipped has a rich and creamy texture, yet it absorbs quickly and feels light on skin. Plus it won't clog pores and leaves skin feeling soft and smooth while helping to protect it from the sun's harmful UV rays.
To view the multimedia release go to:
https://www.multivu.com/players/English/8113551-coppertone-sunscreen-clearlysheer-whipped/
During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
